Design, synthesis and primary activity evaluation of l-arginine derivatives as amino-peptidase N/CD13 inhibitors

Bioorganic & Medicinal Chemistry
2009.0

Abstract

A series of L-arginine derivatives were designed, synthesized and assayed for their activities against amino-peptidase N (APN)/CD13 and metalloproteinase-2 (MMP-2). The results showed that most compounds exhibited high inhibitory activities against APN and low activities against MMP-2. Within this series, two compounds 5q and 5s (IC(50)=5.3 and 5.1 microM) showed similar inhibitory activities compared with bestatin (IC(50)=3.8 microM), which could be used as novel lead compounds for the future APN inhibitors development as anticancer agents.

Knowledge Graph

Similar Paper

Design, synthesis and primary activity evaluation of l-arginine derivatives as amino-peptidase N/CD13 inhibitors
Bioorganic & Medicinal Chemistry 2009.0
Design, synthesis and primary activity assay of bi- or tri-peptide analogues with the scaffold l-arginine as amino-peptidase N/CD13 inhibitors
Bioorganic & Medicinal Chemistry 2010.0
Design, synthesis, and QSAR studies of novel lysine derives as amino-peptidase N/CD13 inhibitors
Bioorganic & Medicinal Chemistry 2008.0
Design, synthesis and biological evaluation of novel 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid derivatives as aminopeptidase N/CD13 inhibitors
Bioorganic & Medicinal Chemistry 2011.0
Novel aminopeptidase N inhibitors derived from antineoplaston AS2–5 (Part II)
Bioorganic & Medicinal Chemistry 2009.0
Design, synthesis and biological evaluation of novel l-lysine ureido derivatives as aminopeptidase N inhibitors
Bioorganic & Medicinal Chemistry 2011.0
Design, synthesis, and preliminary studies of the activity of novel derivatives of N-cinnamoyl-l-aspartic acid as inhibitors of aminopeptidase N/CD13
Bioorganic & Medicinal Chemistry 2009.0
Design, synthesis and biological evaluation of novel amino acid ureido derivatives as aminopeptidase N/CD13 inhibitors
Bioorganic & Medicinal Chemistry 2012.0
Novel leucine ureido derivatives as aminopeptidase N inhibitors. Design, synthesis and activity evaluation
European Journal of Medicinal Chemistry 2016.0
Novel aminopeptidase N (APN/CD13) inhibitors derived from chloramphenicol amine
Bioorganic & Medicinal Chemistry 2011.0